Kissei Pharmaceutical Co., Ltd.
Announcement Regarding Share Buyback Status
There was a resolution to set a cap of up to 1,300,000 shares (3.14%) and a total amount of ¥6,000,000,000; as of June 30, 2026, cumulative totals are 0 shares and ¥0. The purchase period is from 2026/05/12 to 2026/12/31 and is planned to be conducted via market transactions, etc.
Key Figures
- 1,300,000 shares (cap): Maximum number of shares to be acquired
- 3.14%: Percentage of outstanding shares (cap)
- ¥6,000,000,000: Total acquisition amount (cap)
AI要約
Overview
This is an announcement regarding the status of share buyback. From the plan disclosed by the Board on May 11, 2026, the cumulative actuals to date are 0 shares and ¥0. The cap is up to 1,300,000 shares (3.14% of the outstanding shares), and the acquisition period is from 2026/5/12 to 2026/12/31, with market purchases assumed as the method.
Expected impact
Since the cumulative total is 0 shares, the dilutive effect or impact on shareholder value from actual share buybacks has not occurred. Depending on progress, it could affect shareholder value stabilization and market perception.
Kissei Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
